The New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE) is a network of research collaborations that, since 2003, has supported basic science and translational research for the development of preventive and therapeutic interventions against Priority Pathogens listed by NIAID as emerging and re-emerging infectious disease threats. The Center has been a focal point for New England's research and development in Priority Pathogens, and has been applying recent dramatic advances in genomics, proteomics, structural biology, immunology, vaccinology, chemistry, drug screening, and material sciences to problems of importance in combating these threats. The NERCE effort is directed towards catalyzing collaborative work, creative thinking, and innovative solutions to the myriad challenges posed by infectious diseases. NERCE is one of eleven Regional Centers of Excellence located across the country.
The Center has been supported1 by the National Institutes of Allergy and Infectious Disease and has included investigator-initiated research programs and state-of-the-art core laboratories and resources that provide critical services for Priority Pathogen research. The core laboratories have provided services including microbiology and animal model support, large-scale biological molecule production, confocal microscopy, and live-cell imaging to the entire scientific community in New England. Scientists from across the country have made use of the high-throughput small molecule screening laboratory supported by NERCE. The NERCE program has also been registered with the CDC-sponsored Laboratory Response Network and has supported the State of Massachusetts Department of Public Health by providing surge capacity for testing of clinical samples in the case of a biological emergency.
1Support from NIAID for the eleven RCE centers ends February 2014.